A Phase I/II Study of RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas.

Trial Profile

A Phase I/II Study of RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Feb 2016

At a glance

  • Drugs Everolimus (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
  • Indications Cutaneous T cell lymphoma; Peripheral T-cell lymphoma; T cell lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms RADCHOP
  • Most Recent Events

    • 08 Feb 2016 Results of phase II part of this study published in the Annals of Oncology
    • 02 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top